CN Patent

CN119997950A — 用于治疗疾病的单羧酸转运蛋白4的杂环抑制剂的盐

Assigned to Vitor Corp · Expires 2025-05-13 · 1y expired

What this patent protects

本文披露了经取代的吡唑化合物的新盐，这些盐抑制单羧酸转运蛋白MCT4或其突变体的活性。本文还披露了治疗MCT4介导的疾病的化合物、药物组合物和方法，这些疾病诸如炎性障碍和增殖性障碍。

USPTO Abstract

本文披露了经取代的吡唑化合物的新盐，这些盐抑制单羧酸转运蛋白MCT4或其突变体的活性。本文还披露了治疗MCT4介导的疾病的化合物、药物组合物和方法，这些疾病诸如炎性障碍和增殖性障碍。

Drugs covered by this patent

Patent Metadata

Patent number
CN119997950A
Jurisdiction
CN
Classification
—
Expires
2025-05-13
Drug substance claim
No
Drug product claim
No
Assignee
Vitor Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.